PH25714A - 19-substituted progesterone derivatives useful as 19- HYDROXYLASE INHIBITORS - Google Patents

19-substituted progesterone derivatives useful as 19- HYDROXYLASE INHIBITORS

Info

Publication number
PH25714A
PH25714A PH38860A PH38860A PH25714A PH 25714 A PH25714 A PH 25714A PH 38860 A PH38860 A PH 38860A PH 38860 A PH38860 A PH 38860A PH 25714 A PH25714 A PH 25714A
Authority
PH
Philippines
Prior art keywords
hydroxylase inhibitors
derivatives useful
substituted progesterone
progesterone derivatives
substituted
Prior art date
Application number
PH38860A
Other languages
English (en)
Inventor
Gene W Holbert
J O'neal Johnston
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH25714A publication Critical patent/PH25714A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PH38860A 1988-06-28 1989-06-27 19-substituted progesterone derivatives useful as 19- HYDROXYLASE INHIBITORS PH25714A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/212,409 US4910191A (en) 1988-06-28 1988-06-28 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
PH25714A true PH25714A (en) 1991-09-18

Family

ID=22790892

Family Applications (1)

Application Number Title Priority Date Filing Date
PH38860A PH25714A (en) 1988-06-28 1989-06-27 19-substituted progesterone derivatives useful as 19- HYDROXYLASE INHIBITORS

Country Status (20)

Country Link
US (1) US4910191A (de)
EP (1) EP0348910B1 (de)
JP (1) JP2729320B2 (de)
KR (1) KR0160280B1 (de)
CN (1) CN1033032C (de)
AT (1) ATE122681T1 (de)
AU (1) AU610473B2 (de)
CA (1) CA1321578C (de)
DE (1) DE68922660T2 (de)
DK (1) DK167534B1 (de)
ES (1) ES2075014T3 (de)
FI (1) FI92706C (de)
HU (1) HU204066B (de)
IE (1) IE66338B1 (de)
IL (1) IL90727A (de)
NO (1) NO174511B (de)
NZ (1) NZ229696A (de)
PH (1) PH25714A (de)
PT (1) PT90988B (de)
ZA (1) ZA894754B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
EP1330468B1 (de) * 2000-09-18 2007-08-01 Applied Research Systems ARS Holding N.V. Schwefel analoge von 21-hydroxy-6,19-oxidoprogesteronen (21oh-6op) zur behandlung von glucocorticoidüberschuss
DE102006018888A1 (de) * 2006-04-18 2007-10-25 Bayer Schering Pharma Ag Verfahren zur Herstellung von 4-[17beta-Methoxy-17alpha-methoxymethyl-3-oxoestra-4,9-dien-11beta-yl]benzaldehyd-(E)-oxims (Asoprisnil)
ES2524345T3 (es) 2007-04-04 2014-12-05 Sigmoid Pharma Limited Composición farmacéutica oral
DK2471518T3 (en) 2009-05-18 2017-12-04 Sigmoid Pharma Ltd COMPOSITION INCLUDING OIL DROPS
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN102268058B (zh) * 2011-05-24 2012-10-10 湖南诺凯生物医药有限公司 制备17α-羟基孕酮或其类似物的方法
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
CN107106644B (zh) 2014-11-07 2022-04-15 卓越治疗有限公司 包含环孢菌素的组合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1051693A (de) * 1962-07-09
US3275621A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-amino-delta4-pregnenes and-10alpha-pregnenes and process for their preparation
US3275622A (en) * 1963-12-18 1966-09-27 Syntex Corp 19-alkylidene-delta4-3, 20-keto pregnanes
US3558673A (en) * 1966-10-29 1971-01-26 Ormonoterapia Richter Spa 10beta-amino-19-nor-pregnanes and method for the preparation thereof
US3849402A (en) * 1971-01-06 1974-11-19 Steele Chem Co Ltd 19-oxygenated and 19-nor delta8(14)-steroid compounds
US4041055A (en) * 1975-11-17 1977-08-09 The Upjohn Company Process for the preparation of 17α-hydroxyprogesterones and corticoids from androstenes
FR2462445A1 (fr) * 1979-07-31 1981-02-13 Roussel Uclaf Nouveaux derives 17-/(hydroxymethyl) (formamido) methylene/steroides, leur procede de preparation et leur application a l'introduction de la chaine laterale hydroxyacetyle
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
US4289762A (en) * 1980-06-27 1981-09-15 Merrell Dow Pharmaceuticals Inc. 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
US4293548A (en) * 1980-09-02 1981-10-06 Merrell Dow Pharmaceuticals Inc. 18-Substituted pregn-4-ene-3,20-diones
FR2498607A1 (fr) * 1981-01-29 1982-07-30 Roussel Uclaf Nouveau procede de preparation de 17a-hydroxy 17b-hydroxyacetyle steroides, produits intermediaires correspondants et produits finals obtenus
US4495102A (en) * 1982-09-03 1985-01-22 G. D. Searle & Co. Aminoalkyl steroids
US4473564A (en) * 1983-07-12 1984-09-25 Akzo N.V. 19-Thio-androstane derivatives
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant
GB8531745D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynyl-4-9(11)-estradiene derivatives

Also Published As

Publication number Publication date
DE68922660D1 (de) 1995-06-22
HUT51288A (en) 1990-04-28
DE68922660T2 (de) 1996-01-18
AU3712789A (en) 1990-01-04
IL90727A0 (en) 1990-01-18
PT90988B (pt) 1994-11-30
ES2075014T3 (es) 1995-10-01
ZA894754B (en) 1990-05-30
DK318589D0 (da) 1989-06-27
FI92706B (fi) 1994-09-15
KR0160280B1 (ko) 1998-11-16
CN1033032C (zh) 1996-10-16
NZ229696A (en) 1992-03-26
CA1321578C (en) 1993-08-24
IE892086L (en) 1989-12-28
DK318589A (da) 1989-12-29
NO174511C (de) 1994-05-18
JP2729320B2 (ja) 1998-03-18
AU610473B2 (en) 1991-05-16
PT90988A (pt) 1989-12-29
CN1039593A (zh) 1990-02-14
FI92706C (fi) 1994-12-27
EP0348910B1 (de) 1995-05-17
KR910000588A (ko) 1991-01-29
EP0348910A3 (en) 1990-03-21
NO892678L (no) 1989-12-29
ATE122681T1 (de) 1995-06-15
JPH0248598A (ja) 1990-02-19
FI893163A0 (fi) 1989-06-28
IE66338B1 (en) 1995-12-27
HU204066B (en) 1991-11-28
US4910191A (en) 1990-03-20
NO892678D0 (no) 1989-06-27
EP0348910A2 (de) 1990-01-03
FI893163A (fi) 1989-12-29
IL90727A (en) 1993-05-13
DK167534B1 (da) 1993-11-15
NO174511B (no) 1994-02-07

Similar Documents

Publication Publication Date Title
IE840302L (en) 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
AU1071288A (en) Polyolefin stabilising composition
AU2686588A (en) Heterocyclic derivatives of n-carbamoyl-, n-thiocarbamoyl- or n-amidino-glycine or beta-alanine useful as sweetening agents
HK55797A (en) Fluoro substituted benzocycloheptapyridine compounds compositions and methods of use as antihistaminic compounds
AU4840085A (en) Combinations of age inhibitors with dihydropyridines
BR8900004A (pt) Composicoes herbicidas de compostos de heterociclicos-alcoilenos de quinoxaliniloxifenoxipropanoato
EP0310072A3 (de) Nichtpeptide beta-Succinamidoacylaminodiole als antihypertensive Agenzien
EP0350012A3 (de) Antivirale Zusammensetzung
AU7246387A (en) Novel dopamine beta hydroxylase inhibitors
ZA894754B (en) 19-substituted progresterone derivatives useful as 19-hydroxylase inhibitors
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
NZ230711A (en) Substituted thienopyrans as antihypertensive agents
EP0348911A3 (en) 19-fluoro- or cyano- 21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors
EP0297816A3 (en) Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
ZA897253B (en) Novel substituted thienopyrans as antihypertensive agents